Topic · 1 report

FTC Report

RegulationWatch reporting on ftc report matters involving US pharmaceutical manufacturers, PBMs and healthcare companies, newest first.

  1. FTC Report

    FTC interim report finds three PBMs control nearly 80% of US prescriptions amid rebate scrutiny

    The FTC's first interim staff report on pharmacy benefit managers found that the three largest PBMs processed nearly 80% of the 6.6 billion prescriptions dispensed in the US in 2023. The report documented vertical integration with insurers and specialty pharmacies and found PBM-affiliated pharmacies charging substantially higher prices than independents for the same drugs.